Risk factors for bradypnea in a historical cohort of surgical patients receiving fentanyl-based intravenous analgesia

• Published in: JA clinical reports Vol. 4; no. 1; p. 46
• Main Authors: Shiota, Takashi, Kawanishi, Hideaki, Inoue, Satoki, Egawa, Junji, Kawaguchi, Masahiko
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 13.06.2018; Springer Nature B.V; SpringerOpen
• Subjects: Acoustic monitoring; Anesthesiology; Bradypnea; Clinical Research Letter; Critical Care Medicine; Emergency Medicine; Fentanyl; Intensive; Medicine; Medicine & Public Health; Pain Medicine; Postoperative opioid; Postoperative respiratory deterioration; Respiratory rate monitoring; Postoperative opioid; Bradypnea; Respiratory rate monitoring; Postoperative respiratory deterioration; Acoustic monitoring
• ISSN: 2363-9024; 2363-9024
• DOI: 10.1186/s40981-018-0186-x

Introduction The use of both pulse oximetry (SpO 2 ) and respiration rate (RR) monitoring is recommended to prevent the development of respiratory deterioration, particularly after extubation and narcotic analgesic use for pain management. In this study, we investigated the factors contributing to the development of bradypnea in surgical patients receiving fentanyl-based intravenous analgesia after general anesthesia. Methods This study involved a historical chart review of postoperative patients outside an intensive care unit setting. We divided the patients according to the data collected during the first hour postoperatively, into those developing bradypnea (RR < 8 breaths per min for > 2 min) and those with normal RR under oxygen administration. We defined oxygen desaturation as SpO 2 < 90% for > 10 s. We calculated the effect-site concentrations for fentanyl at the end of surgery and 1 h postoperatively using custom-made software based on chart records. A multivariable analysis was used to determine bradypnea-associated explanatory factors. Results For the final analysis, we included 258 patients. We detected bradypnea in 125 patients (48%) and oxygen desaturation in 46 patients (18%). We found no difference in the effect-site fentanyl concentrations between patients with and without bradypnea. The logistic regression model revealed that liver dysfunction [odds ratio (OR), 2.918; 95% confidence interval (CI), 1.329–6.405], renal dysfunction (OR, 0.349; 95% CI, 0.128–0.955), and smoking history (OR, 0.236; 95% CI, 0.075–0.735) were independently associated with bradypnea. We found similar incidences of oxygen desaturation between the groups. Conclusions Bradypnea was observed in 48% of postoperative patients receiving fentanyl-based intravenous analgesia under oxygen therapy. According to our results, impaired liver function associated positively, whereas smoking history associated negatively with its development. Renal dysfunction was paradoxically associated with less incidence of bradypnea.